| Financial Year |
March 31 2023 |
| Monetary Funds |
303,148,882.61 |
| Held-for-trading Financial Assets |
59,324,169.73 |
| Notes Receivable |
32,703,621.01 |
| Accounts Receivable |
939,815,395.34 |
| Advances to Suppliers |
77,746,389.42 |
| Other Receivables |
119,302,849.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
337,164,620.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
86,880,289.36 |
| Total Current Assets |
1,958,586,448.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,271,279,528.13 |
| Under-construction Projects |
309,849,908.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
211,677,581.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
231,422.17 |
| Deferred Income Tax Assets |
64,331,813.66 |
| Other Non-Current Assets |
13,210,403.27 |
| Sub-Total of Non-Current Assets |
1,878,643,790.47 |
| Total Assets |
3,837,230,239.42 |
| Short-Term Loans |
483,300,288.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
90,917,643.89 |
| Accounts Payable |
860,754,696.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,056,443.92 |
| Taxes Payable |
20,876,734.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
319,072,715.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
443,983.62 |
| Other Current Liabilities |
29,819,913.24 |
| Sub-Total of Current Liabilities |
2,065,094,021.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
45,043,100.62 |
| Total Liabilities |
2,110,137,122.54 |
| Paid-In Capital(Or Share Stock) |
443,385,000.00 |
| Capital Surplus |
672,338,151.47 |
| Surplus Reserve |
104,075,853.21 |
| LESS:Treasury Stock |
34,487,950.00 |
| Undistributed Profits |
484,998,803.90 |
| Minority Stockholder's Interest |
56,807,609.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,670,285,507.80 |
| Owner's Equity（Stockholder's Equity） |
1,727,093,116.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,837,230,239.42 |
